Cargando…
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts
Parkinson’s disease (PD) and Multiple System Atrophy (MSA) are clinically distinctive diseases that feature a common neuropathological hallmark of aggregated α-synuclein. Little is known about how differences in α-synuclein aggregate structure affect disease phenotype. Here, we amplified α-synuclein...
Autores principales: | Strohäker, Timo, Jung, Byung Chul, Liou, Shu-Hao, Fernandez, Claudio O., Riedel, Dietmar, Becker, Stefan, Halliday, Glenda M., Bennati, Marina, Kim, Woojin S., Lee, Seung-Jae, Zweckstetter, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893031/ https://www.ncbi.nlm.nih.gov/pubmed/31797870 http://dx.doi.org/10.1038/s41467-019-13564-w |
Ejemplares similares
-
Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein
por: Frieg, Benedikt, et al.
Publicado: (2022) -
Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
por: Zhang, Shuyu, et al.
Publicado: (2023) -
Chicago sky blue 6B inhibits α-synuclein aggregation and propagation
por: Min, Joo-Ok, et al.
Publicado: (2022) -
Interplay between tau and α‐synuclein liquid–liquid phase separation
por: Siegert, Anna, et al.
Publicado: (2021) -
The Molecular Basis of the Interaction of Cyclophilin A with α‐Synuclein
por: Favretto, Filippo, et al.
Publicado: (2020)